Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600116006) titled 'The effect of tegileridine fumarate on pain scores in patients undergoing laparoscopic total hysterectomy for postoperative pain management' on Jan. 4.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Soochow University

Condition: Postoperation pain

Intervention: Tegileridine group:Tegileridine fumarate loading dose: 1 mg (5 ml) 5 mg is diluted with 0.9% normal saline to 100 ml. PCIA self-administration dose: 1 ml, lockout time: 10 minutes. Sufentanil group:Sufentanil loading dose: 10 µg (5 ml)

Recruitment Status: Not Recruiting

Phase: 4

Da...